MedTech Spectrum

Article Name Medtech

Aya Healthcare Expands into UK with ID Medical Acquisition

Aya Healthcare's Global Expansion: ID Medical Acquisition Marks Strategic Entry into the UK Healthcare Market

17th January, 2024

Lunit AI Solutions to Power Samsung's X-ray Devices for Advanced Chest Screening

Three-year supply contract: Lunit INSIGHT CXR and Lunit INSIGHT CXR Triage to enhance lung abnormality detection in Samsung's premium X-ray devices

17th January, 2024

The Human Change campaign launched at World Economic Forum in Davos to make children's mental health a global priority

Human change' is happening now, caused by the over digitalization of children's lives –the world must prioritize the alignment of technological progress with the healthy development of children.

16th January, 2024

Mindray Unveils UX Series Endoscope Camera System, Empowering Surgical Precision with Innovative Technology

Revolutionizing Surgical Visualization: Mindray Introduces UX Series Endoscope Camera System, Elevating Precision through Cutting-Edge Technology

16th January, 2024

Malaysia-based medical device firm Mediven partners with Caring Pharmacy Group

Introducing ProDetect, designed to offer rapid and accurate immunoassay-based diagnostics kits

15th January, 2024

MedTech Company KARL STORZ Acquires British AI Specialist Innersight Labs

KARL STORZ Expands Portfolio with Acquisition of Innersight Labs, Pioneering British AI Expertise in Healthcare

12th January, 2024

3M receives $34.2 million award to improve treatment of traumatic wounds from point-of-injury to hospital

Advancing Trauma Care: 3M Secures $34.2 Million Grant to Enhance Treatment of Traumatic Wounds Throughout the Entire Healthcare Journey

12th January, 2024

New Survey by The Harris Poll Highlights Gaps in Cervical Cancer Screening Access

Survey Conducted in the US, UK and Sweden Exposes Lack of Education on Options and Unclear Guidance on HPV Testing

11th January, 2024

Apollo Hospital Seshadripuram Partners with LifeSigns, inducts advanced AI-Powered 24x7 Remote Patient Monitoring System

Hospital to monitor all patients digitally with the use of technology and biosensors

11th January, 2024

Cleerly® Launches Cleerly® ISCHEMIA™ Solution for Heart Disease Analysis

FDA cleared, evidence-based AI and machine learning-based algorithm detects heart disease-associated ischemia

10th January, 2024

Zavation Introduces 2-Screw ALIF Plating System--Z-Span

Z-Span : Advancements and Clinical Benefits

10th January, 2024

Boston Scientific Announces Agreement to Acquire Axonics, Inc.

Acquisition to expand urology portfolio with differentiated technologies to treat urinary and bowel dysfunction

09th January, 2024

Fresenius Medical Care Executes on Its Strategic Portfolio Optimization Program and Announces Key Transactions

Strategic Divestments and Portfolio Streamlining

09th January, 2024

FDA approves Medtronic Percept™ RC neurostimulator with exclusive BrainSense™ technology

Rechargeable neurostimulator joins the Medtronic Percept™ family – the first and only deep brain stimulation system with sensing, directionality, and advanced programming.

09th January, 2024

Baracoda Unveils BMind, the World's First Smart Mirror for Mental Wellness

Personalized mental health coaching based on mood identiﬁcation available on CareOS operating system

08th January, 2024

Endotronix Submits PMA Application for its Cordella Pulmonary Artery Sensor System

Cordella PA Sensor System's Pivotal Regulatory Step

08th January, 2024

Medtronic receives CE Mark for its next generation Micra leadless pacing systems

New pacemakers offer 40% more battery life, extend Medtronic legacy of pacing leadership

08th January, 2024

“The Open Innovation Program has become a trend in the molecular diagnostics industry”

Established in 2000, South Korea based Seegene Inc is a leader in molecular diagnostics and achieved remarkable financial success with over $1 billion in revenue and 65 per cent gross margins. With a mission for a disease-free world and proactive pandemic prevention, Seegene seamlessly integrates high multiplex diagnostic assays with automated testing systems. In an interaction with BioSpectrum & MedTech Spectrum, Dr Seong-Youl Kim, Seegene's Senior Vice President, shares insights on the company, the molecular diagnostics landscape, challenges and opportunities etc.

08th January, 2024